1. Home
  2. NTRA vs JBL Comparison

NTRA vs JBL Comparison

Compare NTRA & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • JBL
  • Stock Information
  • Founded
  • NTRA 2003
  • JBL 1966
  • Country
  • NTRA United States
  • JBL United States
  • Employees
  • NTRA N/A
  • JBL N/A
  • Industry
  • NTRA Medical Specialities
  • JBL Electrical Products
  • Sector
  • NTRA Health Care
  • JBL Technology
  • Exchange
  • NTRA Nasdaq
  • JBL Nasdaq
  • Market Cap
  • NTRA 21.5B
  • JBL 19.4B
  • IPO Year
  • NTRA 2015
  • JBL 1993
  • Fundamental
  • Price
  • NTRA $159.95
  • JBL $217.36
  • Analyst Decision
  • NTRA Strong Buy
  • JBL Strong Buy
  • Analyst Count
  • NTRA 16
  • JBL 7
  • Target Price
  • NTRA $185.56
  • JBL $213.57
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • JBL 2.0M
  • Earning Date
  • NTRA 08-07-2025
  • JBL 06-17-2025
  • Dividend Yield
  • NTRA N/A
  • JBL 0.15%
  • EPS Growth
  • NTRA N/A
  • JBL N/A
  • EPS
  • NTRA N/A
  • JBL 5.11
  • Revenue
  • NTRA $1,831,000,000.00
  • JBL $28,514,000,000.00
  • Revenue This Year
  • NTRA $19.92
  • JBL N/A
  • Revenue Next Year
  • NTRA $16.02
  • JBL $4.66
  • P/E Ratio
  • NTRA N/A
  • JBL $42.28
  • Revenue Growth
  • NTRA 51.50
  • JBL N/A
  • 52 Week Low
  • NTRA $92.14
  • JBL $95.85
  • 52 Week High
  • NTRA $183.00
  • JBL $219.00
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 54.70
  • JBL 85.71
  • Support Level
  • NTRA $159.50
  • JBL $214.51
  • Resistance Level
  • NTRA $170.48
  • JBL $208.69
  • Average True Range (ATR)
  • NTRA 4.85
  • JBL 5.52
  • MACD
  • NTRA -0.50
  • JBL 1.77
  • Stochastic Oscillator
  • NTRA 56.94
  • JBL 93.43

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

Share on Social Networks: